PharmacyCodes



Minaprinum [Inn-Latin] en es it fr

Minaprinum [Inn-Latin] Brand names, Minaprinum [Inn-Latin] Analogs

Minaprinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Minaprinum [Inn-Latin] Chemical_Formula

C17H22N4O

Minaprinum [Inn-Latin] RX_link

No information avaliable

Minaprinum [Inn-Latin] fda sheet

Minaprinum [Inn-Latin] msds (material safety sheet)

Minaprinum [Inn-Latin] Synthesis Reference

C.G. Wermuth et al., Agressologie 13, 285 (1972)

Minaprinum [Inn-Latin] Molecular Weight

298.383 g/mol

Minaprinum [Inn-Latin] Melting Point

122 oC

Minaprinum [Inn-Latin] H2O Solubility

2360 mg/L

Minaprinum [Inn-Latin] State

Solid

Minaprinum [Inn-Latin] LogP

1.157

Minaprinum [Inn-Latin] Dosage Forms

No information avaliable

Minaprinum [Inn-Latin] Indication

For the treatment of depression

Minaprinum [Inn-Latin] Pharmacology

Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain. Similar to other antidepressant treatments, minaprine attenuates the beta-adrenergic receptor function. Studies have also shown that minaprine improves memory consolidation and that repeated drug administration leads to potentiation of this effect. Moreover, the effects of minaprine on memory consolidation are related to its dopaminergic action.

Minaprinum [Inn-Latin] Absorption

No information avaliable

Minaprinum [Inn-Latin] side effects and Toxicity

No information avaliable

Minaprinum [Inn-Latin] Patient Information

No information avaliable

Minaprinum [Inn-Latin] Organisms Affected

Humans and other mammals